跳转至内容
Merck

810891C

Avanti

DSPE PEG(2000)-N-Cy5

Avanti Research - A Croda Brand, chloroform solution

别名:

1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)-2000]-N-(Cyanine 5)

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C164H299N4O55P
分子量:
3238.10
分類程式碼代碼:
12352211
NACRES:
NA.25

化驗

99% (TLC)

形狀

chloroform solution

包裝

pkg of 1 × 1 mg (
810891C-1MG)

pkg of 5 × 1 mg (
810891C-5MG)

製造商/商標名

Avanti Research - A Croda Brand

濃度

1 mg/mL (810891C-1MG)
1 mg/mL (810891C-5MG)

運輸包裝

dry ice

儲存溫度

−20°C

應用

DSPE PEG(2000)-N-Cy5 is suitable for use to ensure the proper insertion of folic acid to red blood cells (RBCs) membrane by fluorescence microscopy.

生化/生理作用

DSPE PEG(2000)-N-Cy5 is used in the preparation of folic acid and Cy5 modified red blood cells (RBCs) vesicles (FRVs). DSPE PEG(2000)-N-Cy5 is used to demonstrate the modification of RBCs membrane with folic acid. After mixing DSPE PEG(2000)-N-Cy5 with RBC, the non-luminous membrane exhibits bright Cy5 fluorescence, enables visualization with fluorescence microscope.

包裝

5ML Clear Glass Sealed Ampule (810891C-1MG)
5ML Clear Glass Sealed Ampule (810891C-5MG)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

象形圖

Skull and crossbonesHealth hazard

訊號詞

Danger

危險分類

Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3

標靶器官

Central nervous system, Liver,Kidney

儲存類別代碼

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Engineered red blood cells for capturing circulating tumor cells with high performance
Zhu DM, et al.
Nanoscale, 10(13), 6014-6023 (2018)
Erythrocyte derived vesicles for circulating tumor cells capturing and specific tumor imaging
Liu A, et al.
Nanoscale, 11, 12388-12396 (2019)
Ming Chen et al.
Nanoscale, 11(25), 12388-12396 (2019-06-20)
The precise diagnosis of cancer remains a great challenge; therefore, it is our research interest to develop safe, tumor-specific reagents. In this study, we designed nanovesicles derived from erythrocyte membranes; the nanovesicles are capable of recognizing tumor cells for both

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门